Citadel Advisors
RNLX

Citadel Advisors’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Citadel Advisors’s Portfolio RNLX Stock Details RNLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-104,392
Closed -$40.7K – 15648
2023
Q4 		$40.7K Buy
+104,392
New +$83.3K ﹤0.01% 11994
2023
Q2 		– Sell
-12,619
Closed -$28.6K – 15429
2023
Q1 		$30.5K Buy
+12,619
New +$35K ﹤0.01% 12722
2022
Q4 		– Sell
-64,069
Closed -$100K – 15595
2022
Q3 		$82K Sell
64,069
-23,576
-27% -$51.4K ﹤0.01% 11265
2022
Q2 		$215K Sell
87,645
-8,728
-9% -$41.5K ﹤0.01% 10551
2022
Q1 		$667K Sell
96,373
-22,722
-19% -$241K ﹤0.01% 8688
2021
Q4 		$1.89M Buy
119,095
+91,945
+339% +$1.84M ﹤0.01% 6380
2021
Q3 		$544K Buy
27,150
+7,141
+36% +$184K ﹤0.01% 9661
2021
Q2 		$618K Buy
+20,009
New +$599K ﹤0.01% 9546
2021
Q1 		– Sell
-10,905
Closed -$273K – 13835
2020
Q4 		$174K Buy
+10,905
New +$135K ﹤0.01% 9840

Other funds holding RNLX

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.28B AUM 38.1% 1-Year Est. Return
IIC
Ironwood Investment Counsel Scottsdale, Arizona $694M AUM 16.84% 1-Year Est. Return

Citadel Advisors's RNLX Position: Q1 2024 in Review

Citadel Advisors sold out of Renalytix plc American Depositary Shares (RNLX) in Q1 2024, closing a stake of 104,392 shares — an estimated $40.7K sold.

Citadel Advisors first reported a position in RNLX in Q4 2020 and held it in 9 quarters. The position peaked at $1.89M in Q4 2021. 26 funds tracked by Wall St. Rank hold RNLX as of Q1 2024.

  • Citadel Advisors reported no remaining Renalytix plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
  • Citadel Advisors sold 104,392 Renalytix plc American Depositary Shares shares in Q1 2024, an estimated $40.7K.
  • Citadel Advisors first reported a position in Renalytix plc American Depositary Shares in Q4 2020 and held it in 9 quarters.
  • Citadel Advisors's Renalytix plc American Depositary Shares position peaked at $1.89M in Q4 2021.
  • 26 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q1 2024.

Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.